Contact

Our portfolio

Quantib

Quantib focuses on improving patient care by bringing AI radiology solutions into clinical practice. Started in 2012 as a spin-out from Erasmus MC, University Medical Center Rotterdam, Quantib now has AI partnerships with the three largest academic hospitals in the Netherlands and with hospitals and private providers internationally.

  • Institute: Amsterdam UMC
Industry: AI, Digital Health, Imaging
  • Founding year: 2011
Visit website

Want to get in contact about Quantib?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Inreda Diabetic
Improving diabetes management with the AP, a closed-loop bi-hormonal artificial pancreas.
ikHerstel
Speeding up post-surgical rehabilitation with a personalized e-health recovery platform.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
Phlox Therapeutics
Developing RNA-based therapies for rare genetic heart diseases.
Inreda Diabetic
Improving diabetes management with the AP, a closed-loop bi-hormonal artificial pancreas.
ikHerstel
Speeding up post-surgical rehabilitation with a personalized e-health recovery platform.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
Phlox Therapeutics
Developing RNA-based therapies for rare genetic heart diseases.
Explore full AAV portfolio
Contact